RxDoctor Payments Data

Connie Mercer, MD

Family Medicine · Lady Lake, FLNPI 1730128034

Payments from drug & device makers

$475in general payments, 2019–2025

Across 22 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$140
  • Novo Nordisk$114
  • Emergent Biosolutions Inc.$57
  • GSK$55
  • Pfizer$49
  • Merck$23
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$475100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exact Sciences6$140
Novo Nordisk6$114
Emergent Biosolutions Inc.1$57
GSK3$55
Pfizer3$49
Merck1$23
Medtronic1$20
Amgen1$17

How this compares

$475 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$216,443
Medicare patients
604
Services billed
2,500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban87$98,371
JanuviaSitagliptin Phosphate49$78,197
OzempicSemaglutide57$72,538
TrulicityDulaglutide23$42,555
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$31,821
XareltoRivaroxaban14$20,613
MounjaroTirzepatide11$18,876
JardianceEmpagliflozin19$16,856
Tresiba Flextouch U-200Insulin Degludec15$9,516
Repatha SureclickEvolocumab15$9,338
Atorvastatin Calcium640$7,228
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$7,169
Levothyroxine Sodium530$6,396
Omeprazole287$5,727
SymbicortBudesonide/Formoterol Fumarate12$5,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$49$98,37187 claims
MerckJanuvia$23$78,19749 claims
Novo NordiskOzempic$114$72,53857 claims
GSKTrelegy Ellipta$55$31,82141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lady Lake

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →